跳轉至內容
Merck
  • MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.

MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.

Cell death & disease (2018-10-20)
Fan Xuan, Mengying Huang, Erhu Zhao, Hongjuan Cui
摘要

MYC-induced nuclear antigen (MINA53) is a JmjC (jumonji C domain)-containing protein, which is highly expressed in many cancers including glioblastoma. We have revealed in our previous report that MINA53 is a poor prognostic indicator for glioblastoma patients, and knockdown of MINA53 could reduce glioblastoma malignancy. In this study, we found that MINA53 knockdown could decrease the DNA replication initiation in glioblastoma cells. Through further investigations, we revealed that MINA53 could regulate the expression of the CDC45-MCM-GINS (CMG) complex genes, which are vital for DNA replication initiation. Knockdown of MINA53 reduced the CMG genes expression and thus induced DNA replication stress and DNA damage. Furthermore, MINA53 knockdown diminished DNA damage response (DDR) by reducing the ATM/ATR-H2AX pathway activity and finally led glioblastoma cells to apoptosis and death. We further applied a genotoxic drug Doxorubicin and found that MINA53 deficiency sensitized glioblastoma cells to Doxorubicin. Our study reveals that MINA53 is involved in DNA replication initiation and DNA damage response, and provides support for MINA53 as a novel and potential therapeutic target for glioblastoma treatment.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
5-溴-2′-脱氧尿苷, ≥99% (HPLC)
暫時無法取得訂價和供貨情況
Sigma-Aldrich
5-碘-2′-脱氧尿苷, ≥99% (HPLC)
暫時無法取得訂價和供貨情況
Sigma-Aldrich
5-氯-2′-脱氧尿苷, thymidine analog
暫時無法取得訂價和供貨情況